Identification of an essential β chain lysine residue from bovine heart mitochondrial ATPase specifically modified with nitrobenzofurazan  by Sutton, Raul & Ferguson, Stuart J.
Volume 179, number 2 FEBS 2143 January 1985 
Identification of an essential j3 chain lysine residue from 
bovine heart mitochondrial ATPase specifically modified 
with nitrobenzofurazan 
Raul Sutton and Stuart J. Ferguson* 
Department of Biochemistry, University of Birmingham, PO Box 363, Birmingham B15 ZTT, England 
Received 24 August 1984; revised version received 31 October 1984 
A tetrapetide containing an essential ysine residue chemically modified with the nitrobenzofurazan group 
has been purified from bovine heart mitochondrial ATPase. The composition of the peptide indicates that 
this lysine is residue 401 in the sequence of a @ chain. The modification was achieved by incubation at pH 
9 of ATPase that had been previously labelled on a single essential tyrosine residue by reaction of the enzyme 
with 4-chloro-7-nitrobenzofurazan. The specific transfer of the nitrobenzofurazan group from the tyrosine 
residue to a particular lysine residue is consistent with the previously demonstrated intramolecular character 
of this transfer reaction. 
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1. INTRODUCTION 
The mitochondrial ATP synthase enzyme can be 
separated into two structurally distinct parts, a 
water-soluble portion which has catalytic activity, 
usually termed FrATPase, and a membrane-bound 
sector which is a proton-translocating channel, 
usually called Fo. The FrATPase is generally ac- 
cepted to comprise 5 types of polypeptide (CU-c) 
with stoichiometry o$& [l-2]. FrATPase, as 
well as the complete ATP synthase, undergoes an 
unusual chemical modification reaction. At close 
to neutral pH the oxygen atom of a single tyrosine 
residue displaces chloride by nucleophilic attack 
from 4-chloro-7-nitrobenzofurazan (Nbf-Cl) to 
give Nbf-O-tyrosyl-Fr ATPase [3-51. This modi- 
fied enzyme is inactive [3-41. An identical modifi- 
cation reaction has also been observed with 
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FrATPases and ATP synthases from bacteria and 
thylakoids [6-91, suggesting that the reactivity of 
this tyrosine residue, and presumably its microen- 
vironment, is highly conserved. 
When mitochondrial Nbf-0-tyrosyl-FrATPase 
is incubated at pH 9.0 a substantial fraction of the 
Nbf moiety undergoes a transfer to the side chain 
of an amino acid that has been concluded to be 
lysine of a p chain on the basis of spectroscopic 
evidence [lo]. The resulting Nbf-N-FrATPase is in- 
active [lo]. The transfer can be followed from the 
disappearance of absorbance at 385 nm owing to 
Nbf-0-tyrosyl and the increase in absorbance at 
475 nm, which is characteristic of amino- 
substituted Nbf [ 111. Kinetic studies of the absor- 
bance change at different concentrations of en- 
zyme have shown the transfer to be intramolecular 
1101. 
Further understanding of the possible role of the 
tyrosine and lysine residues to which the Nbf group 
can be attached requires identification of the 
modified residues within the amino acid sequence. 
This is not an easy task because of the lability of 
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the Nbf-0-tyrosyl species [4] and the large 
molecular mass, approx. 360 kDa, of the 
FiATPase. The former factor has caused other in- 
vestigators to stabilise by chemical reduction the 
Nbf-0-tyrosyl group before fragmenting the en- 
zyme [ 12,131. Conflicting results have been ob- 
tained [12,13]. We have chosen to study first the 
location of the Nbf group after it has undergone 
intramolecular transfer. The amino-Nbf bond is 
relatively stable and therefore is easier to handle 
than Nbf-0-tyrosyl. Nevertheless, the method 
developed here might also be applicable to the dif- 
ficult task of isolating a peptide containing the 
Nbf-0-tyrosyl species. 
2. MATERIALS AND METHODS 
Pepsin was purchased from Sigma, Nbf-Cl from 
Aldrich and [U-14C]Nbf-Cl (109 Ci/mol) was from 
CEA (France) via Fluorochem Ltd, Dinting Vale, 
Glossop, England. Formic acid was redistilled 
from A.R. Grade. Trifluoroacetic acid was ob- 
tained from Pierce and acetonitrile, far UV grade, 
from Fisons. Sephadex G25 superfine was bought 
from Pharmacia and the Zorbex C8 column from 
DuPont. 
All spectrophotometric measurements were 
made using a Kontron Uvikon 810 instrument. 
Bovine heart mitochondrial FtATPase was 
prepared as described in Sutton and Ferguson [5]. 
A molecular mass of 360 kDa for FrATPase was 
used in all calculations. Protein was assayed by a 
dye binding method using Coomassie blue [ 141. 
Nbf was determined using extinction coefficients 
of 11600 M-‘-cm-’ [4] and26000 M-‘.cm-’ [15] 
from Nbf-0-tyrosyl and amino-Nbf respectively. 
HPLC was carried out using Waters Associates 
pumps and model 660 solvent gradient program- 
mer. The eluate was monitored using a variable 
wavelength UV detection system of Cecil In- 
struments. Amino acid analyses were made on 
hydrolysates (18 h treatment with 6 M HCl con- 
taining 0.5% phenol) of peptides using a Beckman 
4400 automated analyser. 
3. RESULTS 
3.1. Labelling of FIA TPase on a specific 
by Nbf 
100 nmol of FrATPase were desalted on 
284 
lysine 
a col- 
umn of Sephadex G25 (fine grade) equilibrated 
with 0.25 M sucrose, 50 mM triethanolamine- 
HCl, 4 mM ATP, 2 mM EDTA adjusted to pH 7.5 
with NaOH (buffer A) and diluted to 3.6 mg . ml- ’ 
with buffer A. [‘4C]Nbf-C1 (spec. act. 
30 Ci. mol-‘) was added to a final concentration 
of 100pM and the solution incubated at 30°C in 
the dark. A 1 ml aliquot was transferred to the 
spectrophotometer and the progress of the reaction 
was followed at 385 nm. After 60 min the reaction 
was close to completion and the entire sample was 
transferred to a light-proof tube containing 4 g 
(NH&Sod. The resulting suspension of protein 
was left to stand for 15 min at 0°C. This ammo- 
nium sulphate suspension was then centrifuged for 
5 min in a microfuge at 4°C. The pellet was 
resuspended in a minimal volume of buffer A and 
desalted on a column of G25 Sephadex 
equilibrated in buffer A. At this stage the yield of 
FrATPase was 90 nmol and contained 1 mol of 
label bound to the tyrosyl residue and 0.1 mol 
bound to a lysyl residue per mol of enzyme as 
judged by the absorbances at 385 and 475 nm, 
respectively. Measurement of radioactivity indi- 
cated a total incorporation of 1.1 mol Nbf per mol 
of FiATPase. 
Next, the pH of the solution of Nbf-modified 
ATPase (4.5 mg protein.ml-‘) was raised to 9.0 by 
addition of triethanolamine. After 15 h incubation 
at 30°C the visible absorption spectrum [lo] 
showed that 0.8 mol per mol of FiATPase of 
nitrobenzofurazan was bound to a lysyl residue 
and none to a tyrosyl residue. Analysis of the 14C 
content of 5 nmol of the enzyme showed that 
0.8 mol Nbf per mol of enzyme was bound. 
3.2. Digestion of Nbf-N-FlATPase with pepsin 
Formic acid was added to the remaining 85 nmol 
enzyme to a final concentration of 15% (v/v) and 
the sample dialysed against 800 vols 1% (v/v) for- 
mic acid at 4°C. At the end of the dialysis the 
precipitated enzyme contained 65 nmol nitroben- 
zofurazan, as judged by the 14C content. 2OOpg 
pepsin was added to the precipitated enzyme. After 
incubation for 5 h at 30°C the precipitate had 
disappeared reflecting the greater solubility in 1% 
(v/v) formic acid of the pepsin-generated peptides. 
The absorbance at 475 nm of this material in- 
dicated that it contained 65 nmol of amino-Nbf 
label. 
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3.3. Gel filtration of pepsin-generated peptides 
The pepsin-digest was lyophilised, dissolved in 
2 ml 1% (v/v) formic acid and chromatographed 
on a column of Sephadex G-25 (superfine grade) 
equilibrated in lcr/o (v/v) formic acid. The elution 
profile is shown in fig. 1. Of the 50 nmol Nbf 
recovered from the column, 30 nmol eluted in 
fractions 85-95 (peak B). This elution position was 
later than that observed for cobalt acetate which 
indicates that material in these fractions was 
retarded by attractive forces between the column 
matrix and the Nbf group. Table 1 shows that 60% 
of the recovered Nbf group was in the peptides 
eluting in fractions 85-95. 
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3.4. High-performance liquid chromatography 
(HPLC) of peak B fractions 
Fractions 85-95 from the Sephadex G-25 col- 
umn were pooled, lyophilised, dissolved in 0.1% 
trifluoroacetic acid and chromatographed on a 
Zorbex C8 column. The elution profile is shown in 
fig.2. The amino-Nbf group was monitored at its 
shorter wavelength maximum of 345 nm [lo] 
rather than at 475 nm. The profile of absorbance 
at 345 nm shows that the Nbf-containing material 
eluted as a single peak, indicative of a single pep- 
tide. The material collected in this peak was 
yellow/orange in colour with an absorbance max- 
imum at 475 nm, which is characteristic of amino- 
Nbf [lo], as was the colour of the fluorescence 
Fig. 1. Chromatography of pepsin-generated p ptides of 
Nbf-labelled FlATPase on Sephadex G-25. 65 nmol 
labelled FrATPase in 1% formic acid was loaded onto a 
column (160 x 2.2 cm) that contained Sephadex G-25 
superfine quilibrated with 1% (v/v) formic acid. 5.8 ml 
fractions were collected and the absorbance was 
continuously monitored at 277 nm. 10 ,~l was taken 
from each fraction for determination of [14C]Nbf 
content by scintillation counting. The elution positions 
of blue dextran and cobalt acetate were determined in a 
emitted from the sample. The absorbance at 
280 nm relative to 345 or 475 nm was low whereas 
a spectrum of peak B from the Sephadex column 
showed that its absorbance at 280 nm was com- 
parable with that at 475 and greater than at 
January 1985 
separate run. 
Table 1 
Purification of the Nbf-labelled peptide 
Stage in preparation nmol [ 14C]Nbf 
Of stage 
% yield 
Normalised relative to 
starting material 
FrATPase labelled on tyrosine by Nbf 
After transfer of Nbf to lysine 
After digestion with pepsin 
Gel filtration 
fractions 85-95 (peak B) 
fractions 70-77 (peak A) 
fractions 35-55 
1st HPLC 
2nd HPLC 
90 - 100 
72 80 80 
65 96a 76 
30 
15 77 
5 
25 83 
15 75b 
35 
18 
6 
30 
23 
a Calculated on basis that only 68 nmol of Nbf-N-FrATPase was digested with pepsin 
b Calculated on basis that 20 nmol was subject to 2nd HPLC step 
285 
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Fig.2. Elution profile of peak B fractions on HPLC. The absorbance at 345 nm (-) was determined in a separate 
run from that in which the absorbance at 210 nm (---) was followed. After loading the sample the column was 
washed for 5 min with 0.1% aqueous trifluoroacetic acid. Then gradients of acetonitrile in 0.1% trifluoroacetic acid 
(-----) were applied; O-20070 (2 min); 20-40070 (20 min). Application of a further gradient of acetonitrile, 40-90‘70 
(3 min) followed by 90% acetonitrile in 0.1% trifluoroacetic acid (3 min) and 90-O% acetonitrile in 0.1% 
trifluoroacetic acid (2 min) did not elute any additional material containing the Nbf group. Flow rate of the column 
was 1 ml.min-‘. 
345 nm. These observations are consistent with 
purification by HPLC of a peptide that lacked 
aromatic amino acids (table 2). Amino acid 
analyses of fractions collected within this peak are 
shown in table 2. The lysine content was low 
relative to threonine, valine and leucine. This was 
attributed to only partial degradation of a 
nitrobenzofurazan-lysine bond during hydrolysis 
of the peptide. The amino acid analysis revealed an 
unknown species which was presumably Nbf-N-c- 
lysine. Table 2 shows that the relative content of 
glycine was high and thus the peptide was again 
subjected to HPLC, but using a shallower gradient 
of 20-35070 acetonitrile with a run time of 30 min 
rather than the conditions shown in fig.2. An 
amino acid analysis of the repurified peptide is 
shown in table 2. The glycine content, was reduced 
from the first analysis whilst the content of 
threonine, leucine, valine and lysine was very 
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Table 2 
Amino acid analyses of purified Nbf-labelled peptide 
Amino acid After 1st HPLC After 2nd HPLC 
mol per Residue mol per Residue 
mol Nbf per mol mol Nbf per mol 
Thr 0.88 0.92 0.83 0.91 
Ser 0.22 - _ _ 
Glx 0.27 - - - 
Gly 0.36 - 0.17 - 
Val 0.97 1.01 0.95 1.04 
Leu 1.01 1.06 0.95 1.04 
LYS 0.53 0.56 0.62 0.64 
Others <0.2 _ <0.15 _ 
The Nbf content (2.8 nmol of sample from 1st HPLC 
and 3.57 nmol from 2nd HPLC) was calculated from the 
absorbance at 475 nm. Residue per mol is calculated 
relative to the three major amino acids 
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similar. It was concluded that the peptide con- 
tained the amino acids threonine, leucine, valine 
and lysine in equimolar quantities. 
4. DISCUSSION 
The data presented in table 2 show that a single 
tetrapeptide containing the Nbf group has been 
purified. Apart from lysine the other three amino 
acids present do not possess ide chains that could 
be derivatised by Nbf and account for the absor- 
bance maximum at 475 nm. This consideration, 
together with the substoichiometric amount of 
lysine determined in the amino acid analysis, at- 
tributed to partial breakdown of the Nbf-N-lysine 
species during the hydrolysis of the tetrapeptide, 
means that Nbf must have transferred to lysine 
upon incubation of Nbf-0-tyrosyl-FrATPase at 
pH 9.0. Thus the original conclusion [lo], which 
was based on spectroscopic data alone, is justified. 
Inspection of the amino acid sequence of the fl 
chain of FrATPase [16] reveals that only lysine 401 
could be part of a peptide containing equimolar 
valine, threonine and leucine. The sequence of the 
peptide is therefore lys-leu-thr-val. In agreement 
with this conclusion N-terminal analysis by dan- 
sylation of the tetrapeptide followed by acid 
hydrolysis gave no evidence for dansyl derivatives 
of leucine, valine or threonine. 
The identified tetrapeptide contained approx. 
60% of the [14C]Nbf that was applied to the 
Sephadex G-25 column (fig. 1). The composition of 
the material containing the remaining 40% has not 
been investigated but it could arise for three 
reasons: (1) incomplete pepsin digests; (2) incor- 
poration of Nbf on lysine during the initial la- 
belling of the FrATPase by Nbf-Cl; (3) transfer of 
Nbf group from Nbf-0-tyrosyl ATPase to lysine 
residues other than 401. However, the finding that 
at least 60% of the Nbf was found on lysine 401 
substantiates the previous conclusion that an in- 
tramolecular transfer occurred. An intermolecular 
transfer would have resulted in a widespread 
distribution of Nbf amongst he lysine residues of 
FrATPase. 
Lysine 401 is conserved in the enzyme from 
Escherichia coli but not by thylakoid FrATPase 
where it is replaced by arginine [16]. This might 
suggest hat this residue is not catalytically essen- 
tial, although for the purposes of binding a 
negatively charged substrate these two amino acids 
might be equivalent. However, lysine 401 lies in the 
middle of a highly conserved sequence in the 
FrATPases [16]. This indicates that this region of 
the polypeptide may have functional importance. 
From the comparative sequence data it might be 
predicted that the transfer of Nbf from tyrosyl to 
lysine would be similar to mitochondrial FrATPase 
for the E. coli enzyme but different or absent for 
the thylakoid enzyme. Information is limited on 
this point although the transfer for the E. coli en- 
zyme has been reported to be slower than for the 
mitochondrial enzyme [8]. A transfer reaction has 
been reported for the thylakoid enzyme [ 171, but in 
common with the E. coli enzyme it has not been 
reported whether this is an intramolecular process. 
Presumably the tyrosine residue to which Nbf 
initially attaches is within fairly close proximity to, 
and has good accessibility to, lysine 401. However, 
as shown elsewhere [5] lysine 401 must be suffi- 
ciently distant from the tyrosine to account for the 
absence of steric hindrance to reaction between the 
tyrosine of Nbf-N-FrATPase and Nbf-Cl. The 
location of the tyrosine within the /3 chain is uncer- 
tain because whereas Ho and Wang [12] have 
assigned it to tyrosine 197, Andrews et al. [13] have 
concluded that tyrosine 311 is modified. The 
strategy for identifying Nbf-containing peptides 
used here, and earlier in part by Aboderin and 
Boedefeld [ 181, uses acidic conditions in which the 
0-Nbf group is relatively stable. Hence extension 
of the approach used here may identify the reactive 
tyrosine without the need for reduction of the Nbf 
group [ 12,131. It is possible that the reduction pro- 
cess is responsible for the two different locations 
reported for this tyrosine residue [ 12,131. 
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